Safety and Tolerability of Sacubitril/Valsartan in Heart Failure Patient With Reduced Ejection Fraction

NCT05387967 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

121

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure, Systolic

Interventions

DRUG: Sacubitril/valsartan

Sponsor

National Institute of Cardiovascular Diseases, Pakistan